EVEREST ORGANICS
Back to Cashflow Statement
|
EVEREST ORGANICS Last 5 Year Cash Flow from Operating Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹-5.38 Cr | ₹16 Cr | ₹18 Cr | ₹14 Cr | ₹14 Cr |
What is the latest Cash Flow from Operating Activities ratio of EVEREST ORGANICS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹-5.38 Cr |
| Mar2024 | ₹16 Cr |
| Mar2023 | ₹18 Cr |
| Mar2022 | ₹14 Cr |
| Mar2021 | ₹14 Cr |
How is Cash Flow from Operating Activities of EVEREST ORGANICS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-5.38 Cr | Negative | |
| Mar2024 | ₹16 Cr | -12.61 | |
| Mar2023 | ₹18 Cr | 34.06 | |
| Mar2022 | ₹14 Cr | 1.51 | |
| Mar2021 | ₹14 Cr | - | |
Compare Cash Flow from Operating Activities of peers of EVEREST ORGANICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EVEREST ORGANICS | ₹391.9 Cr | -14.8% | -10.1% | 61.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹386,905.0 Cr | -6.8% | -7.6% | -4.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,357.0 Cr | -6.6% | -5.8% | 4.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,788.0 Cr | 0.9% | 5.7% | 27.3% | Stock Analytics | |
| CIPLA | ₹110,628.0 Cr | -4.8% | -8.1% | -3.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,441.5 Cr | -2% | -8.8% | -12.9% | Stock Analytics | |
EVEREST ORGANICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EVEREST ORGANICS | -14.8% |
-10.1% |
61.4% |
| SENSEX | -2.1% |
-3% |
6.8% |
You may also like the below Video Courses